Honz Pharmaceutical Co., Ltd. (300086.SZ)

CNY 5.5

(-0.9%)

Market Cap (In CNY)

2.5 Billion

Revenue (In CNY)

739.56 Million

Net Income (In CNY)

11.52 Million

Avg. Volume

15.39 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.35-7.3
PE
-
EPS
-
Beta Value
0.779
ISIN
CNE100000QM6
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Jiangtao Hong
Employee Count
-
Website
https://www.honz.com.cn
Ipo Date
2010-05-26
Details
Honz Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pediatric medicines in China. It offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal and digestive, cough, anti-flu, antipyretic, anti-infection, anti-fungal, antipyretic-analgesic, and endocrine. The company markets its products through a network of agents and sales terminals. The company was formerly known as HaiNan Honz Pharmaceutical Co.,Ltd. and changed its name to Honz Pharmaceutical Co., Ltd. in November 2016. Honz Pharmaceutical Co., Ltd. is headquartered in Guangzhou, China.